Abstract: Buoyant dimpled golf ball having CoR ?0.810, specific gravity <1.00 g/cc, initial velocity ?250 ft/s, first aerodynamic coefficient magnitude between about 0.25 and about 0.30 and first aerodynamic force angle between about 29 degrees and 34 degrees at Reynolds Number of 230000 and spin ratio of 0.085; and second aerodynamic coefficient magnitude between about 0.26 and about 0.31 and second aerodynamic force angle between about 31 degrees and 36 degrees at Reynolds Number of 180000 and spin ratio of 0.101. Golf ball may additionally have third aerodynamic coefficient magnitude between about 0.27 and about 0.32 and third aerodynamic force angle between about 34 degrees and 39 degrees at Reynolds Number of 133000 and spin ratio of 0.133; and fourth aerodynamic coefficient magnitude between about 0.33 and about 0.38 and fourth aerodynamic force angle between about 38 degrees and 43 degrees at Reynolds Number of 89000 and spin ratio of 0.183.

Abstract: A body implantable ventricular cardioverting system. Circuitry is provided which detects the onset of a malignant ventricular tachyarrhythmia and provides a cardioverting signal in response thereto. The cardioverting signal has an energy level that is high relative to the pacing threshhold but below that necessary for defibrillation. In this manner, a ventricular tachyarrhythmia can be cardioverted before the onset of fibrillation and at a lower energy than required for defibrillation. Dependent on such factors as patient threshholds, the tissue/electrode interface and the electrode system employed, the energy level of the cardioverting signal is from 5 millijoules to 15 joules. The system can be configured such that increasingly malignant tachyarrhythmias result in higher energy cardioverting signals, including signals capable of defibrillation.

Abstract: A body implantable ventricular cardioverter. Circuitry is provided which detects the onset of a malignant ventricular tachyarrhythmia and provides a cardioverting signal in response thereto. The cardioverting signal has an energy level that is high relative to the pacing threshold but below that necessary for defibrillation. In this manner, a ventricular tachyarrhythmia can be cardioverted before the onset of fibrillation and at a lower energy than required for defibrillation. Dependent on such factors as patient thresholds, the tissue/electrode interface and the electrode system employed, the energy level of the cardioverting signal is from 5 millijoules to 15 joules. The system can be configured such that increasingly malignant tachyarrhythmias result in higher energy cardioverting signals, including signals capable of defibrillation.

Abstract: Apparatus for processing waveform signals of physiological origin. The apparatus includes circuitry for developing a signal representative of the peak-to-peak amplitude between each waveform signal peak and the next successive waveform signal peak as well as circuitry for developing a signal representative of the slew rate of the waveform signal between successive waveform signal peaks. In a preferred embodiment, developed signals are stored in resettable memories, the memories being reset on the occurrence of a sign or polarity change in the slope of the waveform signal. Sampling circuitry is provided for establishing a maximum peak-to-peak amplitude within the waveform signal as well as its associated slew rate. Within the context of an ECG, the maximum peak-to-peak amplitude and associated slew rate represent the QRS complex and the apparatus of the present invention may be employed within a pacemaker as a sense amplifier.